Medical R&D news, white papers, reports, and events from PharmaLeaders. New content daily, on our website and delivered right to your inbox.
Providers and vendors team up for user-friendly EHRs Before an Allscripts electronic health record appears on screen, it first appears on a storyboard—sometimes even a paper one. That’s where Allscripts developers can test new ideas on providers, figuring out what should go where. “The design on paper is still at the basic level where we can change on a dime,” said Ross Teague, director ... Read More
Breastfeeding image joins the throng of emojis A London neonatal nurse thought there was something missing from the array of available emojis: one representing a mother breastfeeding. So Rachel Lee, who works at University College London Hospital, petitioned the Unicode Consortium, the not-for-profit corporation that sets global standards for emojis and other software. At the time there was just the baby emoji and one ... Read More
New CMS quality measure tool in the works The CMS is looking to give providers a look behind the curtain on how performance measures are developed. The agency is creating an online resource known as the CMS Measures Inventory Tool, or CMIT, which will provide a comprehensive list of measures being developed and in use, as well as those that have been removed from ... Read More
Telemedicine is still hindered by limited reimbursement Just as part of the Black Friday madness has moved online, so too has part of Black Friday healthcare, as more people, in their Thanksgiving hangovers, seek care virtually. That reflects not only the fact that telehealth use tends to increase right after a holiday but also a broader shift toward digital care across the ... Read More
Pediatric Gene Therapy The European approvals of Glybera® in 2012 and Strimvelis® in 2016 seem likely to be the vanguard of the therapeutic revolution heralded by the decoding of the human genome. Both of these treatments originated from academic centers of excellence and became the subjects of agreements with pharmaceutical companies (Uniqure/Chiesi and GSK, respectively) with the experience ... Read More
The Case for Intelligent Design (and Infrastructure) in Life Science Biologics R&D New White Paper from IDC Health Insights examines industry trends, new challenges and emerging capabilities in biologics. With many recent blockbuster patents expiring, the pharmaceutical industry finds itself in the middle of a transformation. Leading life science organizations are updating their business strategies to include the pursuit of a new market opportunity – the discovery and development ... Read More